Chris Larkins | Senior Vice President of Manufacturing Operations
CSL Seqirus

Day 3 - Thursday 2nd April @ 11:30

Panel: Strain Selection for Respiratory Vaccines: Aligning Science, Strategy & Schedules

li>
•     Timing tensions between flu (Feb–Mar) and COVID (May–Jun) strain selection.
•     Understanding the epidemiology and selective pressures on respiratory viruses informing strain selection times
•     Platform disparities in speed to market (mRNA vs. protein vs. egg-based).
•     Scientific debate over lineage-level vs. strain-level selection strategies.
•     Impact of combo vaccines on aligning strain selection schedules.
•     Variant unpredictability challenges the value of late-season selections

Darin Edwards, Executive Director, Respiratory Vaccines, Moderna Therapeutics

×

Darin Edwards / Panel: Strain Selection for Respiratory Vaccines: Aligning Science, Strategy & Schedules

Darin Edwards, Executive Director, Respiratory Vaccines,
Moderna Therapeutics

Darin joined Moderna in 2019 as the Head of Immunology in the Infectious Disease Research Group.  During his time at Moderna, Darin has led many efforts to develop novel vaccines using Moderna’s mRNA platform as well as the research efforts to further develop the mRNA platform and to understand key ...

CloseMore

Joshua Nealon, Medical Lead - COVID-19 and Flu/COVID combo, Sanofi

Teresa Hauguel, Senior Director, Seasonal Vaccines, Vaccine Research and Development, Pfizer

×

Teresa Hauguel / Panel: Strain Selection for Respiratory Vaccines: Aligning Science, Strategy & Schedules

Teresa Hauguel, Senior Director, Seasonal Vaccines, Vaccine Research and Development,
Pfizer

Dr. Teresa Hauguel is Senior Director for Seasonal Vaccines within Pfizer Vaccine Research and Development, where she serves as the Research Scientific Lead for the company’s Influenza and COVID vaccine programs. In this role, she provides scientific leadership, shapes research strategy, and drives ...

CloseMore

Chris Larkins, Senior Vice President of Manufacturing Operations, CSL Seqirus

×

Chris Larkins / Panel: Strain Selection for Respiratory Vaccines: Aligning Science, Strategy & Schedules

Chris Larkins, Senior Vice President of Manufacturing Operations,
CSL Seqirus

Chris Larkins is Senior Vice President, Global Operations at CSL, with more than 30 years’ experience in pharmaceutical operations, quality, and supply chain leadership, specialising in vaccines, biologics, and sterile manufacturing. His career spans senior roles across...

CloseMore

Moderator: Jessica Taaffe, Global Health and Science Consultant, Global Renaissance Enterprises

×

Jessica Taaffe / Panel: Strain Selection for Respiratory Vaccines: Aligning Science, Strategy & Schedules

Jessica Taaffe, Global Health and Science Consultant,
Global Renaissance Enterprises

Dr. Jessica Taaffe is a biomedical scientist and global health expert with more than 20 years of experience spanning infectious disease research, vaccine R&D, and global health policy and programs. Her work has focused on HIV, influenza, malaria, tuberculosis, and emerging pandemic...

CloseMore